NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 248 filers reported holding NEOGENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,544,019 | -28.8% | 1,995,448 | -6.9% | 0.00% | -33.3% |
Q2 2023 | $34,459,144 | -6.8% | 2,144,315 | +0.9% | 0.00% | -25.0% |
Q1 2023 | $36,982,672 | +119.8% | 2,124,220 | +16.7% | 0.00% | +100.0% |
Q4 2022 | $16,823,795 | +26.5% | 1,820,757 | +17.9% | 0.00% | 0.0% |
Q3 2022 | $13,299,000 | +23.8% | 1,544,640 | +17.2% | 0.00% | +100.0% |
Q2 2022 | $10,739,000 | +9.6% | 1,317,608 | +63.4% | 0.00% | 0.0% |
Q1 2022 | $9,798,000 | -66.7% | 806,471 | -6.4% | 0.00% | -75.0% |
Q4 2021 | $29,412,000 | -35.9% | 862,030 | -9.4% | 0.00% | -33.3% |
Q3 2021 | $45,889,000 | +15.1% | 951,297 | +7.8% | 0.01% | +20.0% |
Q2 2021 | $39,876,000 | -2.3% | 882,792 | +4.3% | 0.01% | -16.7% |
Q1 2021 | $40,825,000 | +31.4% | 846,443 | +46.7% | 0.01% | +20.0% |
Q4 2020 | $31,058,000 | +20.4% | 576,833 | -17.5% | 0.01% | 0.0% |
Q3 2020 | $25,785,000 | +85.2% | 698,988 | +55.5% | 0.01% | +66.7% |
Q2 2020 | $13,926,000 | -1.7% | 449,518 | -12.4% | 0.00% | -25.0% |
Q1 2020 | $14,171,000 | -21.0% | 513,310 | -16.3% | 0.00% | 0.0% |
Q4 2019 | $17,942,000 | +44.5% | 613,380 | -5.5% | 0.00% | +33.3% |
Q3 2019 | $12,414,000 | -5.6% | 649,243 | +8.3% | 0.00% | -25.0% |
Q2 2019 | $13,153,000 | +2.7% | 599,506 | -4.3% | 0.00% | 0.0% |
Q1 2019 | $12,812,000 | +57.4% | 626,261 | -3.0% | 0.00% | +100.0% |
Q4 2018 | $8,141,000 | -49.8% | 645,631 | -38.9% | 0.00% | -50.0% |
Q3 2018 | $16,225,000 | +855.5% | 1,056,917 | +716.1% | 0.00% | – |
Q2 2018 | $1,698,000 | -20.7% | 129,514 | -50.6% | 0.00% | -100.0% |
Q1 2018 | $2,142,000 | +69.3% | 262,386 | +83.8% | 0.00% | – |
Q4 2017 | $1,265,000 | -76.2% | 142,721 | -70.1% | 0.00% | -100.0% |
Q3 2017 | $5,319,000 | +37.3% | 477,867 | +10.5% | 0.00% | +100.0% |
Q2 2017 | $3,873,000 | -45.0% | 432,305 | -51.5% | 0.00% | 0.0% |
Q1 2017 | $7,036,000 | -20.7% | 891,628 | -13.9% | 0.00% | 0.0% |
Q4 2016 | $8,878,000 | +196.5% | 1,035,950 | +184.5% | 0.00% | 0.0% |
Q3 2016 | $2,994,000 | -9.4% | 364,190 | -11.4% | 0.00% | 0.0% |
Q2 2016 | $3,306,000 | +35.9% | 411,265 | +14.0% | 0.00% | 0.0% |
Q1 2016 | $2,432,000 | +149.4% | 360,817 | +191.3% | 0.00% | – |
Q4 2015 | $975,000 | -61.3% | 123,883 | -71.9% | 0.00% | -100.0% |
Q3 2015 | $2,522,000 | +27.8% | 440,102 | +20.6% | 0.00% | 0.0% |
Q2 2015 | $1,974,000 | -17.4% | 364,881 | -28.7% | 0.00% | 0.0% |
Q1 2015 | $2,389,000 | +91.7% | 511,775 | +71.3% | 0.00% | – |
Q4 2014 | $1,246,000 | -32.1% | 298,696 | -15.2% | 0.00% | -100.0% |
Q3 2014 | $1,836,000 | +385.7% | 352,240 | +208.7% | 0.00% | – |
Q2 2014 | $378,000 | +16.7% | 114,106 | +22.3% | 0.00% | – |
Q1 2014 | $324,000 | -52.1% | 93,278 | -50.2% | 0.00% | – |
Q4 2013 | $677,000 | +223.9% | 187,126 | +169.4% | 0.00% | – |
Q3 2013 | $209,000 | -4.6% | 69,472 | +26.1% | 0.00% | – |
Q2 2013 | $219,000 | – | 55,073 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |